Cristina Elena Niturad,Dorit Lev,Vera M Kalscheuer,Agnieszka Charzewska,Julian Schubert,Tally Lerman-Sagie,Hester Y Kroes,Renske Oegema,Monica Traverso,Nicola Specchio,Maria Lassota,Jamel Chelly,Odeya Bennett-Back,Nirit Carmi,Tal Koffler-Brill,Michele Iacomino,Marina Trivisano,Giuseppe Capovilla,Pasquale Striano,Magdalena Nawara,Sylwia Rzonca,Ute Fischer,Melanie Bienek,Corinna Jensen,Hao Hu,Holger Thiele,Janine Altmüller,Roland Krause,Patrick May,Felicitas Becker,Rudi Balling,Saskia Biskup,Stefan A Haas,Peter Nürnberg,Koen L I van Gassen,Holger Lerche,Federico Zara,Snezana Maljevic,Esther Leshinsky-Silver

Abstract:Genetic epilepsies are caused by mutations in a range of different genes, many of them encoding ion channels, receptors or transporters. While the number of detected variants and genes increased dramatically in the recent years, pleiotropic effects have also been recognized, revealing that clinical syndromes with various degrees of severity arise from a single gene, a single mutation, or from different mutations showing similar functional defects. Accordingly, several genes coding for GABAA receptor subunits have been linked to a spectrum of benign to severe epileptic disorders and it was shown that a loss of function presents the major correlated pathomechanism. Here, we identified six variants in GABRA3 encoding the α3-subunit of the GABAA receptor. This gene is located on chromosome Xq28 and has not been previously associated with human disease. Five missense variants and one microduplication were detected in four families and two sporadic cases presenting with a range of epileptic seizure types, a varying degree of intellectual disability and developmental delay, sometimes with dysmorphic features or nystagmus. The variants co-segregated mostly but not completely with the phenotype in the families, indicating in some cases incomplete penetrance, involvement of other genes, or presence of phenocopies. Overall, males were more severely affected and there were three asymptomatic female mutation carriers compared to only one male without a clinical phenotype. X-chromosome inactivation studies could not explain the phenotypic variability in females. Three detected missense variants are localized in the extracellular GABA-binding NH2-terminus, one in the M2-M3 linker and one in the M4 transmembrane segment of the α3-subunit. Functional studies in Xenopus laevis oocytes revealed a variable but significant reduction of GABA-evoked anion currents for all mutants compared to wild-type receptors. The degree of current reduction correlated partially with the phenotype. The microduplication disrupted GABRA3 expression in fibroblasts of the affected patient. In summary, our results reveal that rare loss-of-function variants in GABRA3 increase the risk for a varying combination of epilepsy, intellectual disability/developmental delay and dysmorphic features, presenting in some pedigrees with an X-linked inheritance pattern.

Spatially clustering de novo variants in CYFIP2, encoding the cytoplasmic FMRP interacting protein 2, cause intellectual disability and seizures

Somatic Variants in New Candidate Genes Identified in Focal Cortical Dysplasia Type II

New insights into the regulatory function of CYFIP1 in the context of WAVE- and FMRP-containing complexes

De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy

De Novo Variants in MAPK8IP3 Cause Intellectual Disability with Variable Brain Anomalies

A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

Clinical features and genotype-phenotype correlations in epilepsy patients with de novo DYNC1H1 variants

CCDC22 variants caused X-linked focal epilepsy and focal cortical dysplasia

A novel de novo frameshift variant in the CHD2 gene related to intellectual and developmental disability, seizures and speech problems

De novo SCAMP5 mutation causes a neurodevelopmental disorder with autistic features and seizures

A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay.

Identification of an Identical De Novo SCAMP5 Missense Variant in Four Unrelated Patients with Seizures and Severe Neurodevelopmental Delay.

Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features.

Neurodevelopmental disorder-associated CYFIP2 regulates membraneless organelles and eIF2α phosphorylation via protein interactors and actin cytoskeleton

Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability, speech delay, and dysmorphism

A recurrent, homozygous EMC10 frameshift variant is associated with a syndrome of developmental delay with variable seizures and dysmorphic features

Haploinsufficiency of Cyfip1 produces fragile X-like phenotypes in mice

De novo variants in GABRA4 are associated with a neurological phenotype including developmental delay, behavioral abnormalities and epilepsy

Identification of CYFIP2 Arg87Cys Ligands via In Silico and In Vitro Approaches

A pathogenic UFSP2 variant in an autosomal recessive form of pediatric neurodevelopmental anomalies and epilepsy

De novo FRMD5 Missense Variants in Patients with Childhood‐Onset Ataxia, Prominent Nystagmus, and Seizures